Catalyst Pharmaceuticals Stock Rises 5% As Session Comes To An End On Monday, Outperforms Market

Shares of Catalyst Pharmaceuticals jumped 5.79% to $3.84 at 15:06 EST on Monday, after two successive sessions in a row of gains. The Nasdaq Stock Market is rising 0.96% to $12,496.70, following yesterday's downward trend, This seems, as yet, a somewhat positive trend trading session today.

Catalyst Pharmaceuticals's last close was $3.63, 37.50% below its 52-week high of $5.28.

Catalyst Pharmaceuticals's Sales

Catalyst Pharmaceuticals's sales growth is 11.6% for the present quarter and 4.6% for the next. The company's growth estimates for the current quarter is 25% and a drop 10% for the next.

Catalyst Pharmaceuticals's Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Catalyst Pharmaceuticals's Stock Top and Bottom Yearly Value

Catalyst Pharmaceuticals's stock is valued at $3.84 at 15:06 EST, way below its 52-week high of $5.28 and way above its 52-week low of $2.55.

Catalyst Pharmaceuticals's Moving Average

Catalyst Pharmaceuticals's value is way above its 50-day moving average of $3.37 and higher than its 200-day moving average of $3.79.